I'm LongbridgeAI, I can summarize articles.On CNBC’s 'Final Trades,' Kevin Simpson selected UnitedHealth Group ahead of its Q3 earnings release, with analysts expecting $4.14 EPS on $111.49B revenue. Malcolm Ethridge chose Goldman Sachs, supported by an HSBC upgrade and raised price target to $995. Joseph Terranova recommended Teradyne, citing better-than-expected Q2 results and strong guidance. Stock performance showed UnitedHealth flat, Goldman Sachs up 1.4%, and Teradyne surging 3.5%.
On CNBC’s “Halftime Report Final Trades,” Kevin Simpson, founder and CEO of Capital Wealth Planning, picked UnitedHealth Group Incorporated (NYSE:UNH).
UnitedHealth Group said it will release its third-quarter financial results on Tuesday, Oct. 13, before the opening bell. Analysts expect the company to report quarterly earnings at $4.14 per share on revenue of $111.49 billion.
Malcolm Ethridge, managing partner at Capital Area Planning Group, named The Goldman Sachs Group, Inc. (NYSE:GS) as his final trade.
Lending support to his choice, HSBC analyst Saul Martinez, on July 21, upgraded Goldman Sachs from Reduce to Hold and raised the price target from $834 to $995.
Don’t forget to check out our premarket coverage here
Joseph M. Terranova, senior managing director for Virtus Investment Partners, recommended Teradyne, Inc. (NASDAQ:TER).
On the earnings front, Teradyne reported better-than-expected second-quarter results on July 28 and issued stronger-than-expected guidance for the current quarter.
The company reported adjusted earnings of $2.47 per share, topping the analyst consensus estimate of $2.09. Revenue more than doubled from a year earlier to $1.329 billion, ahead of the consensus estimate of $1.223 billion.
Price Action:
- UnitedHealth shares slipped 0.01% to close at $375.21 on Thursday.
- Goldman Sachs shares gained 1.4% to close at $951.47 during the session.
- Teradyne shares surged 3.5% to settle at $353.13 on Thursday.
Photo via Shutterstock